{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T03:14:09Z","timestamp":1787109249698,"version":"build-2736575974"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thegreenjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Radiotherapy and Oncology"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1016\/j.radonc.2019.05.023","type":"journal-article","created":{"date-parts":[[2019,6,29]],"date-time":"2019-06-29T17:14:52Z","timestamp":1561828492000},"page":"149-157","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"special_numbering":"C","title":["Clinical and dosimetric predictors of physician and patient reported xerostomia following intensity modulated radiotherapy for nasopharyngeal cancer \u2013 A prospective cohort analysis"],"prefix":"10.1016","volume":"138","author":[{"given":"Kiattisa","family":"Sommat","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashik","family":"Hussain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Whee Sze","family":"Ong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nelson Ling Fung","family":"Yit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James Boon Kheng","family":"Khoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoke Lim","family":"Soong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph Tien Seng","family":"Wee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kam Weng","family":"Fong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terence Wee Kiat","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.radonc.2019.05.023_b0005","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.ijrobp.2009.11.024","article-title":"Clinical outcomes and patterns of failure after intensity-modulated radiotherapy for nasopharyngeal carcinoma","volume":"79","author":"Ng","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2019.05.023_b0010","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.ijrobp.2010.09.011","article-title":"Long-term outcomes of early-stage nasopharyngeal carcinoma patients treated with intensity-modulated radiotherapy alone","volume":"82","author":"Su","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2019.05.023_b0015","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1016\/j.oraloncology.2012.03.001","article-title":"Clinical outcome for nasopharyngeal carcinoma with predominantly WHO II histology treated with intensity-modulated radiation therapy in non-endemic region of China","volume":"48","author":"Zhao","year":"2012","journal-title":"Oral Oncol"},{"key":"10.1016\/j.radonc.2019.05.023_b0020","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.oraloncology.2012.08.013","article-title":"Clinical outcomes and patterns of failure after intensity-modulated radiotherapy for T4 nasopharyngeal carcinoma","volume":"49","author":"C-n","year":"2013","journal-title":"Oral Oncol"},{"key":"10.1016\/j.radonc.2019.05.023_b0025","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/1748-717X-9-60","article-title":"Patterns of local-regional failure after primary intensity modulated radiotherapy for nasopharyngeal carcinoma","volume":"9","author":"Kong","year":"2014","journal-title":"Radiat Oncol (London, England)"},{"key":"10.1016\/j.radonc.2019.05.023_b0030","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/1748-717X-9-87","article-title":"Local failure patterns for patients with nasopharyngeal carcinoma after intensity-modulated radiotherapy","volume":"9","author":"Li","year":"2014","journal-title":"Radiat Oncol (London, England)"},{"key":"10.1016\/j.radonc.2019.05.023_b0035","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.oraloncology.2015.11.015","article-title":"Long-term patterns of relapse and survival following definitive intensity-modulated radiotherapy for non-endemic nasopharyngeal carcinoma","volume":"53","author":"Setton","year":"2016","journal-title":"Oral Oncol"},{"key":"10.1016\/j.radonc.2019.05.023_b0040","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S1470-2045(10)70290-4","article-title":"Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trial","volume":"12","author":"Nutting","year":"2011","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.radonc.2019.05.023_b0045","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1016\/j.ijrobp.2006.06.045","article-title":"Intensity-modulated radiotherapy significantly reduces xerostomia compared with conventional radiotherapy","volume":"66","author":"Braam","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2019.05.023_b0050","doi-asserted-by":"crossref","first-page":"E1481","DOI":"10.1002\/hed.24263","article-title":"Prospective randomized controlled trial to compare 3-dimensional conformal radiotherapy to intensity-modulated radiotherapy in head and neck squamous cell carcinoma: Long-term results","volume":"38","author":"Ghosh-Laskar","year":"2016","journal-title":"Head Neck"},{"key":"10.1016\/j.radonc.2019.05.023_b0055","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.radonc.2012.07.001","article-title":"Three-dimensional conformal radiotherapy (3D-CRT) versus intensity modulated radiation therapy (IMRT) in squamous cell carcinoma of the head and neck: a randomized controlled trial","volume":"104","author":"Gupta","year":"2012","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2019.05.023_b0060","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/j.ijrobp.2006.06.013","article-title":"Xerostomia and quality of life after intensity-modulated radiotherapy vs. conventional radiotherapy for early-stage nasopharyngeal carcinoma: initial report on a randomized controlled clinical trial","volume":"66","author":"Pow","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2019.05.023_b0065","article-title":"Clinical outcomes and prognostic factors of 695 nasopharyngeal carcinoma patients treated with intensity-modulated radiotherapy","volume":"2014","author":"Wang","year":"2014","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.radonc.2019.05.023_b0070","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1016\/j.ijrobp.2015.01.002","article-title":"Concurrent chemo-radiation with or without induction gemcitabine, Carboplatin, and Paclitaxel: a randomized, phase 2\/3 trial in locally advanced nasopharyngeal carcinoma","volume":"91","author":"Tan","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2019.05.023_b0075","doi-asserted-by":"crossref","first-page":"98","DOI":"10.3857\/roj.2015.33.2.98","article-title":"Locoregionally advanced nasopharyngeal carcinoma treated with intensity-modulated radiotherapy plus concurrent weekly cisplatin with or without neoadjuvant chemotherapy","volume":"33","author":"Wee","year":"2015","journal-title":"Radiat Oncol J"},{"key":"10.1016\/j.radonc.2019.05.023_b0080","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/bjc.2013.720","article-title":"Late toxicities after intensity-modulated radiotherapy for nasopharyngeal carcinoma: patient and treatment-related risk factors","volume":"110","author":"Zeng","year":"2014","journal-title":"Br J Cancer"},{"key":"10.1016\/j.radonc.2019.05.023_b0085","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1002\/hed.25545","article-title":"Long-term outcome and pattern of failure for patients with nasopharyngeal carcinoma treated with intensity-modulated radiotherapy","volume":"41","author":"Tian","year":"2019","journal-title":"Head Neck"},{"key":"10.1016\/j.radonc.2019.05.023_b0090","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.oraloncology.2017.03.015","article-title":"Ten-year survival outcomes for patients with nasopharyngeal carcinoma receiving intensity-modulated radiotherapy: An analysis of 614 patients from a single center","volume":"69","author":"Wu","year":"2017","journal-title":"Oral Oncol"},{"key":"10.1016\/j.radonc.2019.05.023_b0095","doi-asserted-by":"crossref","first-page":"160","DOI":"10.4103\/0975-5950.183870","article-title":"Radiation-induced dental caries, prevention and treatment \u2013 A systematic review","volume":"6","author":"Gupta","year":"2015","journal-title":"Natl J Maxillofac Surg"},{"key":"10.1016\/j.radonc.2019.05.023_b0100","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1002\/hed.20045","article-title":"Radiation-induced xerostomia in patients with head and neck cancer: pathogenesis, impact on quality of life, and management","volume":"26","author":"Chambers","year":"2004","journal-title":"Head Neck"},{"key":"10.1016\/j.radonc.2019.05.023_b0105","doi-asserted-by":"crossref","first-page":"2525","DOI":"10.1002\/cncr.22302","article-title":"Radiation-induced xerostomia in patients with head and neck cancer: a literature review","volume":"107","author":"Dirix","year":"2006","journal-title":"Cancer"},{"key":"10.1016\/j.radonc.2019.05.023_b0110","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.ijrobp.2007.04.021","article-title":"Impact of radiation-induced xerostomia on quality of life after primary radiotherapy among patients with head and neck cancer","volume":"69","author":"Jellema","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2019.05.023_b0115","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0360-3016(03)00361-4","article-title":"Quality of life after parotid-sparing IMRT for head-and-neck cancer: a prospective longitudinal study","volume":"57","author":"Lin","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2019.05.023_b0120","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/j.ijrobp.2012.08.030","article-title":"Toxicities affecting quality of life after chemo-IMRT of oropharyngeal cancer: prospective study of patient-reported, observer-rated, and objective outcomes","volume":"85","author":"Hunter","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2019.05.023_b0125","doi-asserted-by":"crossref","first-page":"159","DOI":"10.2307\/2529310","article-title":"The measurement of observer agreement for categorical data","volume":"33","author":"Landis","year":"1977","journal-title":"Biometrics"},{"key":"10.1016\/j.radonc.2019.05.023_b0130","first-page":"517","article-title":"Comparison of patient- and practitioner-reported toxic effects associated with chemoradiotherapy for head and neck cancer","volume":"142","author":"Falchook","year":"2016","journal-title":"JAMAOtolaryngol Head Neck Surg"},{"key":"10.1016\/j.radonc.2019.05.023_b0135","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.ijrobp.2006.05.002","article-title":"Grading xerostomia by physicians or by patients after intensity-modulated radiotherapy of head-and-neck cancer","volume":"66","author":"Meirovitz","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2019.05.023_b0140","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1097\/NCC.0b013e318269040f","article-title":"Comparison between patient-reported and clinician-observed symptoms in oncology","volume":"36","author":"Xiao","year":"2013","journal-title":"Cancer Nurs"},{"key":"10.1016\/j.radonc.2019.05.023_b0145","first-page":"1169","article-title":"Integrating patient-reported outcome measures into routine cancer care: cancer patients' and clinicians' perceptions of acceptability and value","volume":"3","author":"Stover","year":"2015","journal-title":"EGEMS (Wash DC)"},{"key":"10.1016\/j.radonc.2019.05.023_b0150","doi-asserted-by":"crossref","first-page":"3322","DOI":"10.1200\/JCO.2015.61.4115","article-title":"Survivorship and quality of life in head and neck cancer","volume":"33","author":"Ringash","year":"2015","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2019.05.023_b0155","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/S0140-6736(18)32779-X","article-title":"Radiotherapy plus cetuximab or cisplatin in human papillomavirus-positive oropharyngeal cancer (NRG Oncology RTOG 1016): a randomised, multicentre, non-inferiority trial","volume":"393","author":"Gillison","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.radonc.2019.05.023_b0160","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/dju127","article-title":"Recommended patient-reported core set of symptoms to measure in head and neck cancer treatment trials","volume":"106","author":"Chera","year":"2014","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.radonc.2019.05.023_b0165","doi-asserted-by":"crossref","first-page":"2920","DOI":"10.1200\/JCO.2014.55.0707","article-title":"Patient-reported outcomes and survivorship in radiation oncology: overcoming the cons","volume":"32","author":"Siddiqui","year":"2014","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2019.05.023_b0170","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/j.ijrobp.2006.09.021","article-title":"The impact of dose on parotid salivary recovery in head and neck cancer patients treated with radiation therapy","volume":"67","author":"Li","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2019.05.023_b0175","doi-asserted-by":"crossref","first-page":"S58","DOI":"10.1016\/j.ijrobp.2009.06.090","article-title":"Radiotherapy dose-volume effects on salivary gland function","volume":"76","author":"Deasy","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2019.05.023_b0180","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1016\/j.ijrobp.2004.12.076","article-title":"Dose-volume modeling of salivary function in patients with head-and-neck cancer receiving radiotherapy","volume":"62","author":"Blanco","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2019.05.023_b0185","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/S0360-3016(01)01512-7","article-title":"Xerostomia and its predictors following parotid-sparing irradiation of head-and-neck cancer","volume":"50","author":"Eisbruch","year":"2001","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2019.05.023_b0190","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0167-8140(02)00013-0","article-title":"Preservation of parotid function with uncomplicated conformal radiotherapy","volume":"63","author":"Maes","year":"2002","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2019.05.023_b0195","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.oraloncology.2012.07.004","article-title":"Scintigraphic assessment of salivary function after intensity-modulated radiotherapy for head and neck cancer: correlations with parotid dose and quality of life","volume":"49","author":"Chen","year":"2013","journal-title":"Oral Oncol"},{"key":"10.1016\/j.radonc.2019.05.023_b0200","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/S0360-3016(99)00247-3","article-title":"Dose, volume, and function relationships in parotid salivary glands following conformal and intensity-modulated irradiation of head and neck cancer","volume":"45","author":"Eisbruch","year":"1999","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2019.05.023_b0205","doi-asserted-by":"crossref","first-page":"21742","DOI":"10.18632\/oncotarget.7826","article-title":"A prospective study on radiation doses to organs at risk (OARs) during intensity-modulated radiotherapy for nasopharyngeal carcinoma patients","volume":"7","author":"Yao","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.radonc.2019.05.023_b0210","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.radonc.2013.03.006","article-title":"The effect of concomitant chemotherapy on parotid gland function following head and neck IMRT","volume":"106","author":"Miah","year":"2013","journal-title":"Radiother Oncol"}],"container-title":["Radiotherapy and Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814019329354?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814019329354?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T05:08:32Z","timestamp":1759122512000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167814019329354"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":42,"alternative-id":["S0167814019329354"],"URL":"https:\/\/doi.org\/10.1016\/j.radonc.2019.05.023","relation":{},"ISSN":["0167-8140"],"issn-type":[{"value":"0167-8140","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical and dosimetric predictors of physician and patient reported xerostomia following intensity modulated radiotherapy for nasopharyngeal cancer \u2013 A prospective cohort analysis","name":"articletitle","label":"Article Title"},{"value":"Radiotherapy and Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.radonc.2019.05.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}